AND	term1 AND term2	Both terms must be included
OR	term1 OR term2	Either term
NOT	term1 NOT term2	term2 must not appear
""	"term1 term2"	Exact match
()	term1 AND (term2 OR term3)	Grouping terms
?	withdr?w	Single letter wildcard (withdraw, withdrew)
*	withdr*	Multiple letter wildcard (withdraw, withdrawn, withdrawing)
"..."~n	"term1 term2"~n	Proximity (term1 within n words of term2)

Search results

Order by: most recent most popular relevance

Jurisdiction

Work area

Firm name

Date from

Date to

Results:1-10 of 2,414

A Twist On The Old One-Two Punch

Reed Smith LLP
USA
November 2 2018

Not terribly long ago, we had a series of poststoo many to linkthat recounted court decisions rejecting efforts to impose liability on a generic

Taking the Medicine

VdA
Portugal
October 31 2018

Portugal's new Medicine Act has come into effect at a time of good health for Portugal's life sciences sector

CMS considers linking Medicare drug payment rates to international prices

Hogan Lovells
USA
October 30 2018

On October 25, 2018, the Centers for Medicare & Medicaid Services (CMS) issued an Advance Notice of Proposed Rulemaking (ANPRM) describing a potential

First Circuit Rejects Certification of Class that Included Members Who Had Not Suffered Any Injury

Troutman Sanders LLP
USA
October 29 2018

In its decision, United Food & Commer. Workers Unions & Emplrs. Midwest Health Bens. Fund v. Warner Chilcott Ltd., 2018 U.S. App. LEXIS 28920, issued

Teva Sues FDA Alleging Unlawful Interpretation of the Definition of “First Applicant”

Seyfarth Shaw LLP
USA
October 24 2018

The FDA Reauthorization Act of 2017 (FDARA) created a new type of 180-day exclusivity for ANDA applicants applying for approval of certain drugs

Highlights of the USMCA

Miller Thomson LLP
USA, Mexico, Canada
October 11 2018

On September 30, 2018, the United States, Mexico and Canada reached a new trade agreement, the United States-Mexico-Canada Agreement (“USMCA”). This

The Priority Review Voucher: An Untapped Asset

Dilworth IP
USA
October 3 2018

Typically, we think of patents as the main tool that allows for product exclusivity in the pharmaceutical industry. However, exclusivity has a

How often will the FTC use its recently reaffirmed authority to compel disgorgement?

K&L Gates
USA
September 6 2018

The U.S. District Court for the Eastern District of Pennsylvania recently granted the Federal Trade Commission’s (“FTC”) request to compel a branded

Federal Circuit Affirms Tribal Sovereign Immunity Does Not Apply to IPR

Marshall Gerstein & Borun LLP
USA
August 9 2018

The Federal Circuit recently affirmed the PTAB’s decision that tribal immunity cannot be asserted in an IPR (Saint Regis Mohawk Tribe v. Mylan Pharma

PTAB Upholds GILENYA Method of Treatment Patent, Prompting New ANDA Litigation

Jones Day
USA
July 30 2018

In Apotex Inc. v. Novartis AG, IPR2017-00854, Paper 109 (Jul. 11, 2018), the PTAB held that the claims of U.S. Patent No. 9,187,405 were not

Search techniques

Current Search

Refine

Content type

Tags